Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

This summary covers recent health news, including the slow adoption of gene therapy for sickle cell, Glenview Capital's ...

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...

Meanwhile, in Lawton, about a dozen people showed up at the Abundant Life Christian Church to donate blood for the Sickle ...

Beam Therapeutics' pipeline shows promise but remains in early stages with no clinical trial data yet available. Find out why ...

The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...

September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...

Zoe Davis, a 20-year-old student, continues to battle severe sickle cell pain while hoping for relief from new gene therapies ...

Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...

Sickle cell disease (SCD) is a genetic disorder affecting hemoglobin, the protein in red blood cells that carries oxygen. In SCD, the red blood cells become misshapen (sickle-shaped), leading to ...

Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on Agios Pharma (AGIO – Research Report) yesterday and set a ...